Thymus Cancer

+ -Text Size

Other Resources and References TOPICS

References: Thymus cancer detailed guide

Cameron RB, Loehrer PJ, Thomas CR. Neoplasms of the mediastinum. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:871-881.

Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006 Jun;81(6):2328-2334.

Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S260-S2605.

Glisson BS, Movsas B, Scott W. Small-cell lung cancer, mesothelioma, and thymoma. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, eds. Cancer Management: A Multidisciplinary Approach. 11th ed. Lawrence, KS: CMPMedica; 2008:163-168.

Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T; American Cancer Society 2010 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012 Jan-Feb;62(1):30-67.

Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003;76(3):878-884; discussion 884-885.

Lucchi M, Ambrogi MC, Duranti L, et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg. 2005;79:1840-1844.

National Cancer Institute. Physician Data Query (PDQ). Thymoma and Thymic Carcinoma: Treatment. 9/17/2012. Accessed at on January 3, 2014.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Thymomas and Thymic carcinomas. V.1.2014. Accessed at on January 3, 2014.

Rajan A, Carter CA, Berman A, et al. Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial. Lancet Oncol. 2014 Feb;15(2):191-200. Epub 2014 Jan 15.

Riedel RF, Burfeind WR. Thymoma: benign appearance, malignant potential. Oncologist. 2006;11:887-894.

Ronckers CM, McCarron P, Engels EA, Ron E. New Malignancies Following Cancer of the Thyroid and Other Endocrine Glands. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (eds). New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute. NIH Publ. No. 05-5302. Bethesda, MD, 2006. Accessed on 4/18/2014 at

Sovak MA, Aisner SC, Aisner J. Tumors of the pleura and mediastinum. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:1367-1398.

Suster S, Moran CA. Thymoma classification. Current status and future trends. Am J Clin Pathol. 2006;125:542-554.

Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999;17:2280-2289.

Vaena DA, Henley J, Loehrer PJ. Thymoma and thymic carcinoma. In: Pass HI, Carbone DP, Johnson DH, Minna JD, Turrisi AT, eds. Lung Cancer: Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:867-880.

Young JL, Ward KC, Ries LAG. Cancers of rare sites. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Last Medical Review: 02/07/2014
Last Revised: 03/17/2015